KLF4 and osteoporosis: SOX5 was found to be up regulated in human MSCs isolated from bone marrow samples of postmenopausal osteoporosis patients, and it was recognized as a therapeutic target through regulation of the KLF4 signalling pathway in the treatment of this osteoporosis in females [105].